BIOLASE Statistics
Total Valuation
BIOLASE has a market cap or net worth of 402,571. The enterprise value is 15.99 million.
| Market Cap | 402,571 |
| Enterprise Value | 15.99M |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BIOLASE has 36.60 million shares outstanding. The number of shares has increased by 4,128.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 36.60M |
| Shares Change (YoY) | +4,128.33% |
| Shares Change (QoQ) | +8.06% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 3.65% |
| Float | 34.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.00 |
| EV / Sales | 0.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.17 |
Financial Position
The company has a current ratio of 0.66
| Current Ratio | 0.66 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.25 |
| Interest Coverage | -5.27 |
Financial Efficiency
Return on equity (ROE) is -1,241.25% and return on invested capital (ROIC) is -44.57%.
| Return on Equity (ROE) | -1,241.25% |
| Return on Assets (ROA) | -24.09% |
| Return on Capital (ROIC) | -44.57% |
| Revenue Per Employee | 293,159 |
| Profits Per Employee | -101,694 |
| Employee Count | 157 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 2.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.02% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -99.02% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 55.50 |
| Average Volume (20 Days) | 143,284 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, BIOLASE had revenue of 46.03 million and -15.97 million in losses. Loss per share was -0.71.
| Revenue | 46.03M |
| Gross Profit | 15.85M |
| Operating Income | -12.72M |
| Pretax Income | -16.00M |
| Net Income | -15.97M |
| EBITDA | -10.10M |
| EBIT | -12.72M |
| Loss Per Share | -0.71 |
Balance Sheet
The company has 3.44 million in cash and 17.11 million in debt, giving a net cash position of -13.67 million or -0.37 per share.
| Cash & Cash Equivalents | 3.44M |
| Total Debt | 17.11M |
| Net Cash | -13.67M |
| Net Cash Per Share | -0.37 |
| Equity (Book Value) | -3.30M |
| Book Value Per Share | -0.14 |
| Working Capital | -9.85M |
Cash Flow
In the last 12 months, operating cash flow was -13.43 million and capital expenditures -252,000, giving a free cash flow of -13.68 million.
| Operating Cash Flow | -13.43M |
| Capital Expenditures | -252,000 |
| Free Cash Flow | -13.68M |
| FCF Per Share | -0.37 |
Margins
Gross margin is 34.44%, with operating and profit margins of -27.63% and -34.84%.
| Gross Margin | 34.44% |
| Operating Margin | -27.63% |
| Pretax Margin | -34.77% |
| Profit Margin | -34.84% |
| EBITDA Margin | -21.94% |
| EBIT Margin | -27.63% |
| FCF Margin | n/a |
Dividends & Yields
BIOLASE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4,128.33% |
| Shareholder Yield | -4,128.33% |
| Earnings Yield | -6,419.24% |
| FCF Yield | -3,397.91% |
Stock Splits
The last stock split was on July 28, 2023. It was a reverse split with a ratio of 0.01.
| Last Split Date | Jul 28, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
BIOLASE has an Altman Z-Score of -17.05. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.05 |
| Piotroski F-Score | n/a |